Stem cell expansion: control cell environment during scale up with a multiplate bioreactor. NBV symposium New initiatives in animal cell culture : Developments in stem cell cultivation November 22, 2012 Egloff Matthieu, Product Manager Proprietary and Confidential ©2011 ATMI, Inc. All Rights Reserved. AGENDA ATMI Lifesciences Introduction Scaling up stem cell culture Learning from our customers Xpansion Multiplate Bioreactor Importance of controlling cell culture environnement – A case study : Promethera Biosciences Enabling cell therapy manufactuing 2 Proprietary and Confidential ©2011 ATMI, Inc. All Rights Reserved. Artelis’ Mission ATMI – Who we are ATMI LS mission is to be the source of Biopharm process efficiency by providing comprehensive disposable technology solutions that maximize product yield and integrity Advance Technology Materials, Inc. Founded in 1986; IPO in 1992 2011 Revenue $390 M >700 Global employees LifeSciences and Semiconductor business focus Largest Ultra Clean liner company in the world with applications in semi, flat panel & life sciences (>$110 M ) ATMI LifeSciences is a market leader in ultra-clean films, critical fluid handling and bioprocess solutions 3 Proprietary and Confidential ©2011 ATMI, Inc. All Rights Reserved. Integrity™ Line of Single-Use Technologies Sterilizable Packaging (NewformTM) Ultraclean Sterilizable by autoclave, gamma or EtO Custom films; custom sizes INTEGRITY Liquid and Powder Vessels Liquid Storage: BioProcess Vessels (BPVs) Powder Storage: Anti-static Powder Transfer Vessels (PTVs) Supporting accessories INTEGRITY Mixers Fully contained, sterile mixing and storage systems Powder-liquid, powder-powder and liquid-liquid mixing Scalable from 1L to 2000L INTEGRITY Bioreactors Fully-integrated NucleoTM or “open architecture” PadReactorTM iCellisTM fixed bed bioreactor XpansionTM stem cellbioreactor 4 Proprietary and Confidential ©2011 ATMI, Inc. All Rights Reserved. Artelis’ Mission ATMI “problem solving” approach Applications & Development Center ATMI has an approach combining both: Product development and manufacturing Process development and optimization ATMI has an Applications & Development center: Located on the Solvay Group R&T site (Brussels) 500m², 4 fully equipped clean rooms. BL2 and BL3 GMP-grade suites, Class 10,000 (ISO7) environment 45 experienced team including: • Engineers – product design and development • Bioengineers & biologists with former experience in the industry – cell culture process development PD for New Bioreactor development PD Services / Support implementation of our technologies Tech transfer to your facility or to your CMO 5 Proprietary and Confidential ©2011 ATMI, Inc. All Rights Reserved. Learning from our customers (back to 2008) • Discussions with cell therapy companies (EU and USA) • Autologous model high dose / 0,5-2,0 bns cells (MSCs)/batch • ~10,000 patients / year, 3 sites – 3000 treatments per site Manufacturing challenges 3000 treatments / years: Issues Patient safety 20 MLS10 are needed per batch QA/QC challenge – Regulatory 200 aseptic operations per batch related to process Consistency 600.000 aseptic operations a year ~2.000 aseptic operations a day Huge investment with current • No technologies available for large volume mgt technologies • Very high level of CR classification & QA/QC validation Costs limitation Need : Process development and bioreactor design for MSC’s expansion 6 Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Learning from our customers Design fixed by mid-2009 User Requirements & Specifications our rationale To ensure same microenvironment, we need to keep: “We want a bioreactor that allows: • • To replace ~20 MLS10, in a fully closed system, with a controlled growth process Future capacity increase to > 150 cultures in parallel, with a minimum investment in equipment BUT without any change in the microenvironment of cell growth, to minimize RA risks Same material: polystyrene Same type of geometry: plates Same manufacturing: injection molding Same surface treatment: electrostatic degradation Where is space “lost” in standard stacked tray technologies: Thickness of plates: 3mm → Reduce it to 1.0mm (challenge !) Distance between plates: 15mm → Reduce it to 1.6mm Now, we have a stack of plates, like in a MLS, with the same ratio Surface area/Volume culture medium, whit gas exchange means and whith: Sensing, pH, pO2, T, biomass Homogenization means With inlets/outlets for gases/liquids 7 Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Xpansion - Bioreactor design XpansionTM bioreactor is made of : A stacking of circular plates Advanced aeration system pH, pO2, T sensors Means for biomass observation Inlets/outlets for gases/liquids Bottom pumping system Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Xpansion - Controller The controller is a generic system installed on separate skid for measurement & control Several Features of Xpansion controller: Graphical user interface with color display and touch screen operation with security levels: Administrator, operator. Integrated control loops for DO and pH Calibration of pre-calibrated DO and pH sensors: Sensor patches come precalibrated. In-process DO and pH recalibration is possible Agitation control (Speed range from 5 up to 250 rpm) Temperature monitoring Trend display for up to 4 process values (pH, DO, T, Q) Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Xpansion – regulation strategy Gas exchange for ph / DO regulation Stacking of plates creates a central column by design Central column incorporates a silicon coil for gas transfer Media homogeneization Plates incorporate radial slots/apertures Bottom incorporates a pumping system All together allows internal circulation and aeration of culture medium 10 Youtube / Xpansion bioreactor Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Xpansion bioreactors : compact design 4m 0,8m Xpansion MPB-10 Xpansion MPB-50 Xpansion MPB-100 Xpansion MPB-200 10 50 100 200 Growth Surface Area 6120 cm² 30600 cm² 61200 cm² 122400 cm² Media working volume 1,6L 5,6L 11,2L 21,9L 29 cm (11.4 '') 47 cm (18.5 '') 55 cm (21.6 '') 81 cm (31.9 '') 1 5 10 20 # of plates Size Multitray 10stack equivalent Xpansion 200 plates bioreactor offer the same surface as 20 multitray stack 10 plates 11 Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Importance of controlling cell culture environnement Enabling control of cell culture parameters increase process scale up efficiency - Same surface material and geometry as multitray stack Control of the stem cell niche microenvironnement Preserve stem cell integrity & facilitate transfert from multitray stack Regulation of pH and DO Control of the physiochemical environnement Increase process reproductibility & robustness Automated cell counting with holographic microscope Control of the cell density and morphology Mitigate quality risk & harvest time 12 Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Case study – Promethera Biosciences Promethera Biosciences® Belgium Biotech company Cell therapy product to treat children suffering from serious congenital metabolic liver diseases. HepaStem: human heterologous adult liver progenitor cells (ADHLSCs) isolated from healthy human livers. Phase I/II clinical trials treatment of Crigler Najjar (CN) and Urea cycle disorders (UCD) in a pediatric setting Using Corning CellBind treated CellStacks Scale up allogeneics production to support clinical phase and early commercialization 13 Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Control of the surface material and geometry : 2D surface Similar cell growth from multitray stack to Xpansion 180 plates % of cell density at harvest in Xpansion bioreactors VS Cellstack 2 control 140 120 100 80 Xpansion 60 CS2 CTRL 40 20 0 Xpansion 10 Xpansion 50 Xpansion 180 Viability at harvest 97% 98,7% 99% FACS Pass Pass In progress ICC Pass Pass In progress Morphology Pass Pass In progress Activity of CYP3A4 Pass Pass In progress Urea secretion Pass Pass In progress Bilirubin conjugation Pass Pass In progress QC test 14 Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Regulation of pH and DO Regulation of pH & DO enable to increase process reproductibility Xpansion 10 :pH, DO, T trends Xpansion 180 : pH, DO, T trends 15 Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Cell density monitoring Automatic cell counting support cell density monitoring and secure harvest time Observation of cells in the 3 scale of Xpansion, using the holographic microscope - day of harvest Automatic cell counting of cells in Xpansion 10, using the holographic microscope Cell confluency : 50 % 16 Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Xpansion - Cell Cultures performance MSCs, ADSCs, Hepatocyte progenitors grow in XP technology: Confluence, morphology and cell growth comparable to CS Cell harvested: 90% viability (after centrifugation) Homogeneity inter/intra plates QC PASS Xpansion was able to maintain pH, DO, T and homogeneity Vero, MRC-5, A549 derived cells grow in XP technology: Confluence and cell growth comparable to Tflasks Homogeneity inter/intra plates Xpansion was able to maintain pH, DO, T and homogeneity Microscopy observation: Cells density and morphology on the 10 top plates can be monitored Scaling-up completed: In house and at customer sites 17 Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Learning from our customers Bioreactor design Xpansion design achieves URS User Requirements & Specifications “We want a bioreactor that allows: • To replace 20 MLS10, in a fully closed system, with a controlled growth process • Future capacity increase to > 150 cultures in parallel, with a minimum investment in equipment Up to 120000cm² in one container, equivalent to 20MLS … without changes in the microenvironment of cells … leads to similar behavior vs reference processes for several biological materials, as proven by our customers ... That can be controlled, both physical parameters and cell growth by µscopy BUT without any change in the microenvironment of cell growth, to minimize RA risks 18 Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Value proposition By ensuring product safety and consistency, XpansionTM is an enabling technology for stem cells manufacturing: Xpansion allows the customer to benefit from all the advantages of a bioreactor, BUT without any change in the µenvironment of cells, which is UNIQUE Xpansion allows mitigation of RA risks Dramatic reduction of # of operation Process efficiency Closed sytem No change in the structure of cell growth Process safety Process quality consistency Dramatic increase of safety Significant reduction of regulatory risk scalability Mitigate risk Incresa succes rate during clinical phase Process industrialization becomes possible 19 Proprietary and Confidential ©20010 ATMI, Inc. All Rights Reserved. Integrated Solution for Cell Therapies Closed system from pre-culture to final filling to avoid aseptic operations Single use Primary culture kit Harvest ATMI primary cell culture kit Single use Cell expansion kit Single use Centrifugation Kit ATMI Xpansion bioreactor Detachment Washing 1 3 Washing 2 Harvest Cryopreservation solution 6 7 5 Media Bioreactor harvest Media ATMI Centrifugation technology Final container for treatment Waste Rinsing 4 Waste ATMI Integrity™ Bag Tubing Proprietary and Confidential ©2011 ATMI, Inc. All Rights Reserved. ATMI Lifesciences and cell therapies manufacturing – future developments Support large volume manufacturing ( High volume commercial production ) Padreactor™ Allogeneic CT – large dose: Need to increase volumetric productivity ATMI developments: Stay in 2D –move to micro-carriers, with very low shear systems : ATMI padreactor iCELLis™ Move to 3D – packed bed system can be a good way to scale-up :ATMI iCELLis based technology Proprietary and Confidential ©2011 ATMI, Inc. All Rights Reserved. Thank you for your attention Copyright©20010 2009 ATMI, Inc. AllAll Rights Reserved. Proprietary and Confidential ATMI, Inc. Rights Reserved.
© Copyright 2026 Paperzz